Salk Press Releases
Cancer biologists are bringing in the B cell reinforcements
LA JOLLA—Cancer is the second leading cause of death in the United States, according to a 2026 Cancer Research Institute report. Cancer biologists are keenly aware of this statistic, as it drives them to innovations that revolutionize cancer care—innovations like immunotherapy. Immunotherapy fights cancer using the body’s own immune system, and often by boosting the performance of specialized adaptive immune cells called T cells.
Keck Foundation funds three innovative early-career Salk projects
LA JOLLA—Three Salk faculty members, Sung Han, PhD, Daniel Hollern, PhD, and Graham McVicker, PhD, have been chosen as Keck Scholars, alongside corresponding graduate students as Keck Fellows, in a special W. M. Keck Foundation Bridge Funding Initiative. The Initiative comes as the Keck Foundation seeks to support early-career scientists amid federal funding uncertainty.
The Salk Institute welcomes top scientists in cancer biology and biophysics
LA JOLLA—The Salk Institute is pleased to welcome two new assistant professors in the fields of cancer biology and biophysics, respectively. Daniel Hollern and Pallav Kosuri will bring fresh perspectives to advance an understanding of, and find new treatments for, breast cancer and heart disease.